.webp)
Acerca de
Longevity Investors Lunch
Davos, Seehof Hotel
May 25, 2022
Photos & Videos
About
The Longevity Investors Lunch is an invite-only event that creates a platform for exclusive networking and sharing insights into new technologies and research, among prominent scientists, academia, entrepreneurs, and investors.
The reception will bring together 50 VIP guests interested in the longevity-related research and breakthrough technologies and will provide latest insights in the longevity field.
The event is open only to institutional investors interested in the Maximon Longevity Co-investment Fund (minimum ticket of CHF 0.5 million).
The Longevity Investors Lunch is organised by Maximon and the Longevity Investors Conference
Hosts
Marc P. Bernegger
Founding Partner at Maximon
Jörg Rieker
Founding Partner at Maximon
Caroline Wagner
Founding Partner at Maximon
Speakers
Dmitry Kaminskiy
General Partner at Deep Knowledge Group, innovative entrepreneur, investor, author and philanthropist
Thomas Nirnberger
CEO BioFi Virtual Tissue Emulation
Filling in the gap for evidence on the biological mechanism of aging biomarkers (Quant Biomarkers & BioFi example)
Matthias Steger
Founder and CEO Rejuveron
Patrick Burgermeister
Partner at KIZOO Technology Capital
Dr. Dina Radenkovic
Co-founder & CEO of Gameto & Partner, SALT
Dr. Sanja Tomovska
CEO and Managing Partner Quant Biomarkers
Nathalie Giroud
Neuropsychologist at University of Zürich & WEF contributor on Healthy Ageing and Longevity
Sophie Chabloz
CPO at Avea Life
Dr. Yap Seng Chong
Founding Director of the A*STAR-NUS Singapore Centre for Nutritional Sciences, Metabolic Disease, and Human Development, NUHS
Prof. Dr. Collin Y. Ewald
Assistant Professor at ETH Zurich. Founder of Swiss Society for Aging Research
Pascal Kaufmann
Founder and CEO Mindfire
Dr. Rob Konrad Maciejewski
CEO at Biolytica
Program
12.00-12.30
12.30 - 12.40
Intro to longevity
Why is longevity the largest investment opportunity in the decades to come?
12.40 - 13.05
Panel 1: New mega trends in Technology and Science for Healthy Longevity
Panel discussion with scientists and physicians: Where do we stand in research? The status quo of health extension. Which interventions exist to enhance healthspan?
13.05 - 13.15
Keynote presentation by Dmitry Kaminskiy
Dmitry Kaminskiy, General Partner at Deep Knowledge Group will make a Longevity industry overview and talk about the Longevity policy and governance, as well as the Swiss Longevity Valley
13.15 - 13.40
Panel 2: Overview of the latest investing activities and investment landscape
Panel discussion with investors: How to invest in longevity: Fund approach and direct investment approach. How to invest in longevity start-ups?
13.40-14.00
Closing remarks
Introduction to Maximon ventures and closing remarks
14.00-15.00
Networking reception
Organised by
Partners
